DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rdxxch/medipoint_renal) has announced the addition of the "MediPoint: Renal Denervation - Global Analysis and Market Forecasts" report to their offering.
The authors estimates that the renal denervation market in 2012 was valued at $15.5m across the 10 regions covered in this report, which include the United States (US), France, Germany, Italy, Spain, the United Kingdom (UK), Japan, Brazil, China, and India. By the end of the forecast period in 2019, sales will have grown to over $171.7m, with a Compound Annual Growth Rate (CAGR) of 41.01%.
The market is expected to see rapid growth over the course of the forecast period, given the expansion of the intervention into the emerging markets and other indications. In 2012, renal denervation was only approved in the European Union (EU). However, by the end of the forecast period, The authors predicts that the intervention will be approved for use in all the countries covered in this report. Additionally, renal denervation will not solely be indicated for resistant hypertension. Europe is expected to see approval of the intervention in both uncontrolled hypertension patients and heart failure patients.
The United States is also expected to see approval of the indication in uncontrolled hypertension patients.
Barriers Significantly Impede the Market's Adoption
While the renal denervation market is expected to see significant growth over the forecast period, there are several market barriers that are heavily dampening the intervention's potential adoption levels. Notably, reimbursement has been the largest hurdle for the procedure to bear. Health insurance agencies want to see long-term clinical trial data from sophisticated studies, but the longest follow-up to date is three years in a nonrandomized study.
Additionally, the purported efficacy results of the majority of company-sponsored clinical trials have recently come into question, given the use of office-based blood pressure measurements rather than ambulatory measurements. Compounded with several other market barriers, like game-changing technologies from competitors, renal denervation will have to bear a decade of significant scrutiny before the market will really take off and see optimal adoption.
Opportunities to Achieve Competitive Advantage
While there are significant barriers in this market, current and future players can still position themselves to obtain a competitive advantage when the market begins seeing higher adoption rates in the future.
Given that the radiofrequency and ultrasound systems have been able to achieve similar safety and efficacy profiles, competitors will need to offer a differentiator besides the magnitude of blood pressure reductions and a low adverse event profile. Some differentiators include offering significantly different technology that can provide an improvement in the pain levels experienced by the patient, or increasing the simplicity of the procedure for the cardiologist. Additionally, systems that can offer cost savings to the provider will be better poised to compete.
Key Topics Covered:
List of Tables
List of Figures
Introduction
Disease Overview
Marketed Products
Unmet Needs
Pipeline Products
Clinical Trial Analysis
Industry Overview
Current and Future Players
Market Drivers and Opportunities
Country Outlooks and Forecasts
Appendix
List of Tables
List of Figures
Companies Mentioned
Ablative Solutions
ApexNano
Best Medical International
Boston Scientific Corporation
Cardiosonic
Covidien
Cordis Corporation and Johnson & Johnson
Cryomend
Kona Medical
Medtronic
Mercator MedSystems
Northwind Medical
ReCor Medical
Sound Interventions
St. Jude Medical
Symple Surgical
Terumo Corporation
Verve Medical
For more information visit http://www.researchandmarkets.com/research/rdxxch/medipoint_renal
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
